Literature DB >> 7791773

A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation.

H Ishii1, T Yoshida, H Oh, S Yoshida, M Terada.   

Abstract

The K-sam gene was originally cloned from KATO-III human gastric cancer cells and is identical to the bek or keratinocyte growth factor (KGF) receptor (KGFR) or fibroblast growth factor receptor 2 gene. K-sam generates several variant transcripts by alternative splicing, and the most abundant K-sam transcript in KATO-III cells was cloned as the K-sam-IIC3 cDNA, which has the KGF-binding motif and a short carboxyl terminus lacking a putative phospholipase C-gamma 1 association site, Tyr-769. The K-sam-IIC3 cDNA was distinct from the K-sam-IIC1 cDNA, which was the same as the previously reported KGFR cDNA. The K-sam-IIC1 product contains a long carboxyl terminus with Tyr-769. K-sam-IIC3 showed greater transforming activity in NIH 3T3 cells than did K-sam-IIC1, and in gastric cancer cell lines in general, the level of K-sam-IIC3 mRNA was greater than that of K-sam-IIC1 mRNA. Here we report that the K-sam-IIC3 product was less autophosphorylated than the K-sam-IIC1 product in NIH 3T3 transfectants. K-sam-IIC3-transfected keratinocytes showed a stronger mitogenic response to KGF than did K-sam-IIC1 transfectants. Moreover, K-sam-IIC3-transfected L6 myoblast cells hardly differentiated when cultured in differentiation-inducing medium and growth was not significantly affected, while K-sam-IIC1 transfectants showed a differentiated phenotype with a reduced growth rate. These data indicate the difference in the signal transduction mediated by two KGFR-type K-sam variants generated by alternative splicing which might be involved in certain differentiation and carcinogenesis scenarios.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791773      PMCID: PMC230604          DOI: 10.1128/MCB.15.7.3664

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  K-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors.

Authors:  Y Hattori; H Odagiri; O Katoh; H Sakamoto; T Morita; K Shimotohno; K Tobinai; T Sugimura; M Terada
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

Review 2.  Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction.

Authors:  M Jaye; J Schlessinger; C A Dionne
Journal:  Biochim Biophys Acta       Date:  1992-06-10

3.  K-sam gene encodes secreted as well as transmembrane receptor tyrosine kinase.

Authors:  M Katoh; Y Hattori; H Sasaki; M Tanaka; K Sugano; Y Yazaki; T Sugimura; M Terada
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

4.  High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF.

Authors:  G Crumley; F Bellot; J M Kaplow; J Schlessinger; M Jaye; C A Dionne
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

5.  Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor.

Authors:  P Champion-Arnaud; C Ronsin; E Gilbert; M C Gesnel; E Houssaint; R Breathnach
Journal:  Oncogene       Date:  1991-06       Impact factor: 9.867

6.  The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain.

Authors:  T Akiyama; S Matsuda; Y Namba; T Saito; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

7.  A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1.

Authors:  M Mohammadi; A M Honegger; D Rotin; R Fischer; F Bellot; W Li; C A Dionne; M Jaye; M Rubinstein; J Schlessinger
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

8.  Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis.

Authors:  K G Peters; J Marie; E Wilson; H E Ives; J Escobedo; M Del Rosario; D Mirda; L T Williams
Journal:  Nature       Date:  1992-08-20       Impact factor: 49.962

9.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.

Authors:  T Miki; D P Bottaro; T P Fleming; C L Smith; W H Burgess; A M Chan; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

10.  A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.

Authors:  A Yayon; Y Zimmer; G H Shen; A Avivi; Y Yarden; D Givol
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  3 in total

1.  Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion.

Authors:  Zahra Timsah; Zamal Ahmed; Chi-Chuan Lin; Fernando A Melo; Loren J Stagg; Paul G Leonard; Prince Jeyabal; Jonathan Berrout; Roger G O'Neil; Mikhail Bogdanov; John E Ladbury
Journal:  Nat Struct Mol Biol       Date:  2014-01-19       Impact factor: 15.369

2.  Clinical significance of keratinocyte growth factor and K-sam gene expression in gastric cancer.

Authors:  Hideki Tani; Noboru Saito; Makio Kobayashi; Shingo Kameoka
Journal:  Mol Med Rep       Date:  2013-03-27       Impact factor: 2.952

3.  Grb2 controls phosphorylation of FGFR2 by inhibiting receptor kinase and Shp2 phosphatase activity.

Authors:  Zamal Ahmed; Chi-Chuan Lin; Kin M Suen; Fernando A Melo; James A Levitt; Klaus Suhling; John E Ladbury
Journal:  J Cell Biol       Date:  2013-02-18       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.